Besides phosphorylation of eIF2α, increased levels of eIF2α expression are detected in tumor samples in bronchioloalveolar carcinomas of the lung, Hodgkin's lymphoma, gastrointestinal carcinomas, malignant melanoma, and melanocytic neoplasms [70, 85]. This evidence concerns the gene EIF2A and digestive system carcinoma.